Compass Therapeutics (NASDAQ:CMPX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $10.00 to $24.00 in a research report issued on Friday,Benzinga reports ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...

Oncology-focused biopharma Compass Therapeutics (NASDAQ:CMPX) announced Tuesday that tovecimig (CTX-009), its treatment for ...

Leerink Partnrs upgraded shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) from a hold rating to a strong-buy rating in a research note released on Tuesday morning,Zacks.com reports.

Wedbush reiterated their outperform rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report ...

In trading on Thursday, shares of Compass Diversified's 7.875% Series C Cumulative Preferred Shares (Symbol: CODI.PRC) were yielding above the 9% mark based on its quarterly dividend (annualized ...

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) has been given an average rating of “Buy” by the six ratings firms that ...

Leerink Partners upgraded shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) from a market perform rating to an outperform rating in a research report report published on Wednesday, MarketBeat ...

Compass Diversified (Symbol: CODI) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

(RTTNews) - Compass Therapeutics ... CMPX is currently trading at $1.71, down $0.18 or 9.73 percent on the Nasdaq. The views and opinions expressed herein are the views and opinions of the ...

Intech Investment Management LLC increased its holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 218.7% ...

Shares of oncology-focused biopharma Compass Therapeutics (NASDAQ:CMPX) added ~11% in the premarket on Tuesday after the ...